The Valley Desk

NCT01709435 · Interventional trial

Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

Overall registry status Completed

Phase 1

Conditions Recurrent Malignant Solid Neoplasm, Recurrent Melanoma, Recurrent Primary Central Nervous System Neoplasm, Recurrent Thyroid Gland Carcinoma, Refractory Malignant Solid Neoplasm, Refractory Primary Central Nervous System Neoplasm, Thyroid Gland Medullary Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov